CAPR Chart
- 52-Week Range: $2.83 - $5.72
- Market Capitalization: $84.65M
- Short Percentage: 0%
- Target Price: $15.00
- Shares Outstanding: 24.32M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CAPR released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Capricor Therapeutics to Present at the H.C. Wainwright Global Investment ConferenceGlobeNewsWire | May 18th
- Capricor Therapeutics, Inc. (CAPR) CEO Linda Marban on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 10th
- Capricor Therapeutics Names Dr. Daniel Paulson as Vice President of Clinical DevelopmentGlobeNewsWire | March 2nd
- Capricor Therapeutics Announces Key Updates on its Vaccine and Therapeutic Programs for COVID-19GlobeNewsWire | December 13th
- Capricor's CEO Dr. Linda Marbán to Serve as Keynote Speaker at TriLink Annual mRNA DayGlobeNewsWire | November 12th
- Capricor Therapeutics, Inc. (CAPR) CEO Linda Marbán on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 9th
- Capricor Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate UpdateGlobeNewsWire | November 9th
Company Info
Website: https://www.capricor.com
Address: 10865 Road to the Cure, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 48
Address: 10865 Road to the Cure, San Diego, CA, United States, 92121
Sector: Healthcare
Industry: Biotechnology
Full time employees: 48
$CAPR Holding
$CAPR Buying more
$CAPR Don't like that...
$CAPR Holding Strong since January ??????????